Specific Carbohydrate Diet and Mediterranean Diet Lead to Similar Symptom Remission in Crohn Disease
Researchers compared the effectiveness of the specific carbohydrate diet with the Mediterranean diet for the management of Crohn disease symptoms.
Inflammatory Bowel Diseases (IBD)
SARS-CoV-2 Vaccination Effective in Veterans With IBD and Exposure to Immunosuppressive Medications
Researchers evaluated the effectiveness of the SARS-CoV-2 vaccination in the IBD population and the potential impact of immunosuppressive medications.
Bacterial Biofilms Frequently Identified During Endoscopy Among Patients With Irritable Bowel Syndrome or Ulcerative Colitis
Researchers analyzed the presence and effect of mucosal biofilms in patients with irritable bowel syndrome and ulcerative colitis.
Vedolizumab Improves Histologic Remission, Disease Activity Better Than Adalimumab in UC
Investigators compared rates of histologic remission and disease activity in patients with UC treated with vedolizumab vs adalimumab.
Adalimumab Shows Safety and Efficacy in Pediatric Patients With Ulcerative Colitis
Investigators evaluated the safety and efficacy of adalimumab in pediatric patients with moderate to severe ulcerative colitis.
Upadacitinib Improves Symptoms of Ulcerative Colitis
Researchers aimed to evaluate how bowel urgency and abdominal pain may improve with upadacitinib treatment, as indicted by health related quality of life outcomes.
Filgotinib Shows Efficacy in Ulcerative Colitis
Researchers analyzed the safety and efficacy of filgotinib in patients with moderately to severely active ulcerative colitis.
Perianal Crohn Disease Is a Strong Predictor of a Complicated Disease Course
Researchers evaluated perianal involvement in patients with CD and compared disease course in those with severe vs non-severe perianal CD.
Strategies to Overcome the Drug Plateau in IBD
Researchers reviewed how to overcome the plateau in rates of response and remission in patients with IBD.
Ustekinumab Shows Safety and Efficacy in Crohn Disease
Researchers aimed to evaluate the long-term safety and efficacy of ustekinumab in a cohort of patients with Crohn disease with a follow-up of 2 years.
- Loading...
Loading...
Next post in Inflammatory Bowel Diseases (IBD)
Loading... 
Loading...